Results

1–7 of 7 results for Infectious uveitis

Medical Case Conference: Sreenivasa Basavanthappa, MD
Sreenivasa Basavanthappa, MD
Annual Meeting Talks
2024
Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
Annual Meeting Talks
2024
Real-World Treatment Practices Among Newly Diagnosed Patients With Noninfectious Uveitis in the United States
On Demand Cases, Courses, and Papers
2022
Post Hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis
Shree K. Kurup, MD
Annual Meeting Talks
2020
Course of Macular Edema Through 36 Months With Fluocinolone Acetonide Intravitreal Insert for Non-infectious Uveitis Affecting the Posterior Segment
Seenu M. Hariprasad, MD
Annual Meeting Talks
2020
Post-Hoc Fellow Eye Analyses Support SAKURA Program Findings on Vitreous Haze, Visual Acuity and Macular Edema in Noninfectious Uveitis
Pauline T. Merrill, MD, FASRS
On Demand Cases, Courses, and Papers
2018
Suprachoroidally Injected CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveitis: Results of the Phase 3 PEACHTREE Study
Steven Yeh, MD
Annual Meeting Talks
2018